gout and allopurinol Archives - ACR Meeting Abstracts

Abstract Number: 361 • ACR/ARP Annual Meeting 2019
Frequency of Allopurinol Dose Reduction in Hospitalized Patients with Gout Flares
Irvin Huang¹, Alison Bays ² and Jean Liew ³, ¹University of Washington - Boise Internal Medicine Residency, Boise, ID, ²University of Washington Division of Rheumatology, Seattle, WA, ³University of Washington, Seattle, WA
Background/Purpose: It is a common misconception that allopurinol should either be held or reduced during gout flares and renal insufficiency. However, current guidelines recommend the…
Abstract Number: 1222 • ACR/ARP Annual Meeting 2019
Relationships Between Allopurinol Dose, Oxypurinol Levels and Serum Urate – in Search of an Oxypurinol Therapeutic Concentration
Lisa Stamp¹, Peter Chapman ², Murray Barclay ³, Anne Horne ⁴, Christopher Frampton ³, Tony Merriman ⁵, Daniel Wright ⁶, Jill Drake ³ and Nicola Dalbeth ⁴, ¹University of Otago, Christchurch, Christchurch, Canterbury, New Zealand, ²Christchurch Hospital, Christchurch, New Zealand, ³University of Otago, Christchurch, Christchurch, New Zealand, ⁴University of Auckland, Auckland, New Zealand, ⁵University of Otago, Birmingham, AL, ⁶University of Otago, Dunedin, New Zealand
Background/Purpose: Lack of a standardised allopurinol dose, with marked inter-individual variation in the dose required to achieve target urate contribute to failure to reach target…

Abstracts tagged "gout and allopurinol"